A new role for myosin II in vesicle fission

PLoS One. 2014 Jun 24;9(6):e100757. doi: 10.1371/journal.pone.0100757. eCollection 2014.

Abstract

An endocytic vesicle is formed from a flat plasma membrane patch by a sequential process of invagination, bud formation and fission. The scission step requires the formation of a tubular membrane neck (the fission pore) that connects the endocytic vesicle with the plasma membrane. Progress in vesicle fission can be measured by the formation and closure of the fission pore. Live-cell imaging and sensitive biophysical measurements have provided various glimpses into the structure and behaviour of the fission pore. In the present study, the role of non-muscle myosin II (NM-2) in vesicle fission was tested by analyzing the kinetics of the fission pore with perforated-patch clamp capacitance measurements to detect single vesicle endocytosis with millisecond time resolution in peritoneal mast cells. Blebbistatin, a specific inhibitor of NM-2, dramatically increased the duration of the fission pore and also prevented closure during large endocytic events. Using the fluorescent markers FM1-43 and pHrodo Green dextran, we found that NM-2 inhibition greatly arrested vesicle fission in a late phase of the scission event when the pore reached a final diameter of ∼ 5 nm. Our results indicate that loss of the ATPase activity of myosin II drastically reduces the efficiency of membrane scission by making vesicle closure incomplete and suggest that NM-2 might be especially relevant in vesicle fission during compound endocytosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Endocytosis / drug effects
  • Endocytosis / physiology
  • Exocytosis / drug effects
  • Exocytosis / physiology
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Mast Cells / drug effects
  • Mast Cells / metabolism
  • Mice
  • Myosin Type II / antagonists & inhibitors
  • Myosin Type II / metabolism*
  • Protein Binding
  • Pyridinium Compounds / metabolism
  • Quaternary Ammonium Compounds / metabolism
  • Transport Vesicles / drug effects
  • Transport Vesicles / metabolism*

Substances

  • FM1 43
  • Heterocyclic Compounds, 4 or More Rings
  • Pyridinium Compounds
  • Quaternary Ammonium Compounds
  • blebbistatin
  • Myosin Type II

Grants and funding

This work was supported by the Ministerio de Ciencia e Innovación ISCIII and Fondos FEDER Grant PI11/00257 (to E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.